Oral News and Research

RSS

UniSA researchers unearth potential cure for obesity

It costs the global economy an estimated US$2 trillion annually and has been dubbed a modern day health epidemic, but new research from the University of South Australia has unearthed a possible cure for obesity – and it is as plain as dirt!

31 Aug 2018

Clinical trial: Promising drug slows brain shrinkage in progressive MS patients

A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease.

30 Aug 2018

Dectin-1 pathway could be important new target for treatment of candidiasis, study shows

Candida albicans infection (candidiasis) can cause skin, genital, or oral pain. Many studies have attempted to understand the source of pain in candidiasis; none have provided a clear explanation, until now.

29 Aug 2018

Routine oral care to treat gum disease may improve cognitive function in cirrhosis patients

Routine oral care to treat gum disease may play a role in reducing inflammation and toxins in the blood and improving cognitive function in people with liver cirrhosis.

29 Aug 2018

Crowdsourcing campaigns improve HIV testing in China, study finds

Approximately 14 million people living with HIV worldwide have yet to be tested, impacting the effectiveness of HIV treatment and prevention programs.

29 Aug 2018

Tips to know your ovarian cancer risk and symptoms

Ovarian cancer is the fifth leading cause of death in American women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. And according to the National Cancer Institute, approximately 22,240 women will be diagnosed with the disease in 2018; 14,070 will die from it.

28 Aug 2018

Novel treatment can shorten hospital stays for few patients with endocarditis

A new treatment can halve hospital stays for some patients with a heart infection, according to late breaking results of the POET trial presented today in a Hot Line Session at ESC Congress 2018 and published in the New England Journal of Medicine.

28 Aug 2018

Combined oral anticoagulant and antiplatelet therapy linked to poor prognosis in atrial fibrillation

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for antiplatelets, according to late breaking results from the GARFIELD-AF registry presented today at ESC Congress 2018.

28 Aug 2018

New smartphone app can help detect atrial fibrillation

A smartphone application can help in screening for atrial fibrillation, according to late breaking results from the DIGITAL-AF study presented at ESC Congress.

28 Aug 2018

Taking vacations could prolong life, suggests new study

Taking vacations could prolong life. That's the finding of a 40-year study presented today at ESC Congress and accepted for publication in The Journal of Nutrition, Health & Aging.

28 Aug 2018

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

TB Alliance has initiated a pivotal clinical trial, SimpliciTB, that will evaluate whether a new four-drug regimen can treat most types of tuberculosis including multidrug-resistant TB more quickly and effectively than currently-available treatments.

28 Aug 2018

Immune-related enzymes cause aggressive skin cancer in patients with Butterfly Syndrome

Patients with a rare skin disease, commonly called Butterfly Syndrome, that causes chronic blistering and extensive scarring also develop an aggressive and fatal form of cancer early in life.

28 Aug 2018

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.

27 Aug 2018

Study: 1 in 12 children taking multiple medications at risk of drug-drug interactions

According to new research from the University of Illinois at Chicago, about one in five children regularly use prescription medications, and nearly one in 12 of those children are at risk for experiencing a harmful drug-drug interaction.

27 Aug 2018

Study: 40% of patients with atrial fibrillation may have unknown brain damage

Four out of ten patients with atrial fibrillation but no history of stroke or transient ischaemic attack have previously unknown brain damage, according to the first results of the Swiss Atrial Fibrillation Cohort Study presented today at ESC Congress 2018.

27 Aug 2018

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.

27 Aug 2018

Gut microbial signature may help identify causes of chronic malnutrition in children

Chronic malnutrition, usually associated with an inflammation of the small intestine, affects one in every four children under the age of five. It is the leading cause of child mortality in low-income countries and is also responsible for severe stunting.

24 Aug 2018

Research uncovers unexpected upside of E. coli

Best known as a pathogen that causes food poisoning or steals nutrients away from its host, the E. coli bacterium actually plays a critical role in promoting health by producing a compound that helps cells take up iron, new CU Boulder research shows.

24 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

A form of vitamin B3 shows potential to prevent acute kidney injury

Acute kidney injury, an often fatal condition without a specific treatment, affects up to 10 percent of all hospitalized adults in the United States and 30-40 percent in low-income countries.

21 Aug 2018

Oral News and Research

UniSA researchers unearth potential cure for obesity

Clinical trial: Promising drug slows brain shrinkage in progressive MS patients

Dectin-1 pathway could be important new target for treatment of candidiasis, study shows

Routine oral care to treat gum disease may improve cognitive function in cirrhosis patients

Crowdsourcing campaigns improve HIV testing in China, study finds

Tips to know your ovarian cancer risk and symptoms

Novel treatment can shorten hospital stays for few patients with endocarditis

Combined oral anticoagulant and antiplatelet therapy linked to poor prognosis in atrial fibrillation

New smartphone app can help detect atrial fibrillation

Taking vacations could prolong life, suggests new study

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

Immune-related enzymes cause aggressive skin cancer in patients with Butterfly Syndrome

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Study: 1 in 12 children taking multiple medications at risk of drug-drug interactions

Study: 40% of patients with atrial fibrillation may have unknown brain damage

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

Gut microbial signature may help identify causes of chronic malnutrition in children

Research uncovers unexpected upside of E. coli

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

A form of vitamin B3 shows potential to prevent acute kidney injury

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News